Systemic treatment-free period following dupilumab discontinuation for atopic dermatitis: A nationwide cohort study.
There is limited data regarding discontinuation of dupilumab in atopic dermatitis (AD). This study aimed to determine the proportion of patients with a systemic treatment-free period of ≥12 months following dupilumab discontinuation, and to describe patient characteristics and care trajectories. We conducted a cohort study including 7,214 patients with severe AD treated with dupilumab for ≥6 months. Overall, 900 patients (12%) discontinued dupilumab for ≥12 months, without switching to another systemic treatment. Within this group, 72% remained off-systemic treatment throughout the follow-up, 22% restarted treatment with dupilumab and 6% switched to another systemic treatment. Patients who did not receive further systemic treatment tended to be older and, in the year following discontinuation, required fewer topical corticosteroids and fewer dermatologist consultations compared to patients who restarted systemic treatment. In conclusion, among patients who discontinued dupilumab for ≥12 months, most did not receive further systemic treatment throughout follow-up, suggesting that a systemic treatment-free period may be achievable in AD.
Authors
- Lucie‐Marie Scailteux (ORCID: https://orcid.org/0000-0001-7047-9107)
- Sandrine Kerbrat (ORCID: https://orcid.org/0000-0003-4119-203X)
- C. Droitcourt (ORCID: https://orcid.org/0000-0001-6714-6643)
- Delphine Staumont-Sallé (ORCID: https://orcid.org/0000-0002-4780-4212)
- Marion Gundelwein (ORCID: https://orcid.org/0009-0001-1158-7631)
Institutions
- Inserm (FR)
- École des Hautes Études en Santé Publique (FR)
- Université de Lille (FR)
- Institut de Recherche en Santé, Environnement et Travail (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Institute for Translational Research in Inflammation (FR)
- Université de Rennes (FR)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1093/ced/llag467
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00